02 Breast cancer non clinical

Breast cancer (Non-clinical)
18. Ching HC, Naidu R, Seong MK, et al. Integrated analysis of copy number and loss
of heterozygosity in primary breast carcinomas using high-density SNP array. Int J
Oncol 2011;39(3):621-633.
46. Ch'ng ES, Tuan Sharif SE, Jaafar H. In human invasive breast ductal carcinoma,
tumor stromal macrophages and tumor nest macrophages have distinct
relationships with clinicopathological parameters and tumor angiogenesis. Virchows
Arch 2013;462(3):257-267.
49. Naidu R, Har YC, Taib NA. Polymorphic variant Ser128Arg of E-Selectin is
associated with breast cancer risk and high grade tumors. Onkologie
2011;34(11):592-597.
58. Ahmad FK, Deris S, Othman NH. The inference of breast cancer metastasis
through gene regulatory networks. J Biomed Inform 2012;45(2):350-362.
59. Naidu R, Wahab NA, Yadav M, et al. Protein expression and molecular analysis of
c-myc gene in primary breast carcinomas using immunohistochemistry and
differential polymerase chain reaction. Int J Mol Med 2002;9(2):189-196.
61. Er HM, Cheng EH, Radhakrishnan AK. Anti-proliferative and mutagenic activities
of aqueous and methanol extracts of leaves from Pereskia bleo (Kunth) DC
(Cactaceae). J Ethnopharmacol 2007;113(3):448-456.
62. Nesaretnam K, Ambra R, Selvaduray KR, et al. Tocotrienol-rich fraction from
palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in

athymic mice. Lipids 2004;39(5):459-467.
63. Jabir RS, Naidu R, Annuar MA, et al. Pharmacogenetics of taxanes: impact of
gene polymorphisms of drug transporters on pharmacokinetics and toxicity.
Pharmacogenomics 2012;13(16):1979-1988.
65. Nesaretnam K, Dorasamy S, Darbre PD. Tocotrienols inhibit growth of ZR-75-1
breast cancer cells. Int J Food Sci Nutr 2000;51 Suppl:S95-103.
70. Nassar ZD, Aisha AF, Al Suede FS, et al. In vitro antimetastatic activity of
koetjapic acid against breast cancer cells. Biol Pharm Bull 2012;35(4):503-508.
72. Nesaretnam K, Ambra R, Selvaduray KR, et al. Tocotrienol-rich fraction from
palm oil and gene expression in human breast cancer cells. Ann N Y Acad Sci
2004;1031:143-157.
74. Norhaizan ME, Ng SK, Norashareena MS, et al. Antioxidant and cytotoxicity
effect of rice bran phytic acid as an anticancer agent on ovarian, breast and liver
cancer cell lines. Malays J Nutr 2011;17(3):367-375.

1

78. Wong SF, Reimann K, Lai LC. Effect of transforming growth factor-beta1, insulinlike growth factor-I and insulin-like growth factor-II on cell growth and oestrogen
metabolism in human breast cancer cell lines. Pathology 2001;33(4):454-459.
79. Chin LF, Kong SM, Seng HL, et al. Synthesis, characterization and biological

properties of cobalt(II) complexes of 1,10-phenanthroline and maltol. J Inorg
Biochem 2011;105(3):339-347.
84. Naidu R, Wahab NA, Yadav MM, et al. Expression and amplification of cyclin D1
in primary breast carcinomas: relationship with histopathological types and clinicopathological parameters. Oncol Rep 2002;9(2):409-416.
95. Kang P, Mariapun S, Phuah SY, et al. Large BRCA1 and BRCA2 genomic
rearrangements in Malaysian high risk breast-ovarian cancer families. Breast Cancer
Res Treat 2010;124(2):579-584.
96. Zhou Q, Cheung YB, Jada SR, et al. EGFR Intron 1 polymorphism in Asian
Populations and its correlation with EGFR gene expression and amplification in
breast tumor tissues. Cancer Biol Ther 2006;5(11):1445-1449.
97. Naidu R, Wahab NA, Yadav M, et al. Detection of amplified int-2/FGF-3 gene in
primary breast carcinomas using differential polymerase chain reaction. Int J Mol
Med 2001;8(2):193-198.
98. Lee AS, Ho GH, Oh PC, et al. Founder mutation in the BRCA1 gene in Malay
breast cancer patients from Singapore. Hum Mutat 2003;22(2):178.
100. Balraj P, Khoo AS, Volpi L, et al. Mutation analysis of the BRCA1 gene in
Malaysian breast cancer patients. Singapore Med J 2002;43(4):194-197
http://www.sma.org.sg/smj/4304/4304a5.pdf
105. Naidu R, Har YC, Taib NA. Genetic polymorphisms of TP53-binding protein 1
(TP53BP1) gene and association with breast cancer risk. APMIS 2011;119(7):460467.

119. Othman EQ, Kaur G, Mutee AF, et al. Immunohistochemical expression of
MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues. J Clin Lab Anal
2009;23(4):249-258.
120. Bakar AF, Alitheen NB, Keong YS, et al. A mouse IgM monoclonal antibody
recognizes breast and colon cancer. Hybridoma (Larchmt) 2009;28(3):199-203.
121. Ng JH, Kalanithi N, Reimann K, et al. Effect of retinoic acid and palm oil
carotenoids on oestrone sulphatase and oestradiol-17beta hydroxysteroid
dehydrogenase activities in MCF-7 and MDA-MB-231 breast cancer cell lines. Int J
Cancer 2000;88(1):135-138
http://onlinelibrary.wiley.com/doi/10.1002/10970215%2820001001%2988:1%3C135::AID-IJC21%3E3.0.CO;2-S/pdf

2

134. Naidu R, Har YC, Taib NA. Analysis of peptidyl-propyl-cis/trans isomerase 1
(PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast
cancer risk and clinico-pathological parameters. Scand J Clin Lab Invest
2011;71(6):500-506.
135. Naidu R, Har YC, Taib NA. Glyoxalase I Ala111Glu gene polymorphism: No
association with breast cancer risk but correlated with absence of progesterone
receptor. Pathol Int 2010;60(9):614-620.

140. Ghrici M, El Zowalaty M, Omar AR, et al. Newcastle disease virus Malaysian
strain AF2240 induces apoptosis in MCF-7 human breast carcinoma cells at an early
stage of the virus life cycle. Int J Mol Med 2013;31(3):525-532.
141. Fauzi AN, Norazmi MN, Yaacob NS. Tualang honey induces apoptosis and
disrupts the mitochondrial membrane potential of human breast and cervical cancer
cell lines. Food Chem Toxicol 2011;49(4):871-878.
142. Loganathan R, Selvaduray KR, Nesaretnam K, et al. Tocotrienols promote
apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase
cleavage and inhibiting nuclear factor kappa-B activity. Cell Prolif 2013;46(2):203213.
143. Muniandy SV, Stanslas J. Modelling of chromatin morphologies in breast cancer
cells undergoing apoptosis using generalized Cauchy field. Comput Med Imaging
Graph 2008;32(7):631-637.
144. Tan ML, Sulaiman SF, Najimuddin N, et al. Methanolic extract of Pereskia bleo
(Kunth) DC. (Cactaceae) induces apoptosis in breast carcinoma, T47-D cell line. J
Ethnopharmacol 2005;96(1-2):287-294.
145. Ramdas P, Rajihuzzaman M, Veerasenan SD, et al. Tocotrienol-treated MCF-7
human breast cancer cells show down-regulation of API5 and up-regulation of MIG6
genes. Cancer Genomics Proteomics 2011;8(1):19-31.
146. Hasima N, Aun LI, Azmi MN, et al. 1'S-1'-acetoxyeugenol acetate: a new
chemotherapeutic natural compound against MCF-7 human breast cancer cells.

Phytomedicine 2010;17(12):935-939.
147. Chien AL, Pihie AH. Styrylpyrone derivative induces apoptosis through the upregulation of Bax in the human breast cancer cell line MCF-7. J Biochem Mol Biol
2003;36(3):269-274.
148. Tee TT, Cheah YH, Hawariah LP. F16, a fraction from Eurycoma longifolia jack
extract, induces apoptosis via a caspase-9-independent manner in MCF-7 cells.
Anticancer Res 2007;27(5A):3425-3430.
149. Tee TT, Azimahtol HL. Induction of apoptosis by Eurycoma longifolia jack
extracts. Anticancer Res 2005;25(3B):2205-2213.

3

151. Doustjalali SR, Yusof R, Yip CH, et al. Aberrant expression of acute-phase
reactant proteins in sera and breast lesions of patients with malignant and benign
breast tumors. Electrophoresis 2004;25(14):2392-2401.
153. Tan ML, Tan HK, Oon CE, et al. Identification of genes involved in the regulation
of 14-deoxy-11,12-didehydroandrographolide-induced toxicity in T-47D mammary
cells. Food Chem Toxicol 2012;50(2):431-444.
155. Naidu R, Har YC, Taib NA. P27 V109G Polymorphism is associated with lymph
node metastases but not with increased risk of breast cancer. J Exp Clin Cancer Res
2007;26(1):133-140.

156. Looi LM, Azura WW, Cheah PL, et al. pS2 expression in infiltrating ductal
carcinoma of the breast correlates with oestrogen receptor positivity but not with
histological grade and lymph node status. Pathology 2001;33(3):283-286.
160. Leong PP, Mohammad R, Ibrahim N, et al. Phenotyping of lymphocytes
expressing regulatory and effector markers in infiltrating ductal carcinoma of the
breast. Immunol Lett 2006;102(2):229-236.
162. Kumar DH, Kutty MK. Review of stem cell deregulation and breast cancer: an
emerging hypothesis. Indian J Pathol Microbiol 2012;55(2):147-153.
168. Nesaretnam K, Jin Lim E, Reimann K, et al. Effect of a carotene concentrate on
the growth of human breast cancer cells and pS2 gene expression. Toxicology
2000;151(1-3):117-126.
170. Khamis S, Bibby MC, Brown JE, et al. Phytochemistry and preliminary biological
evaluation of Cyathostemma argenteum, a malaysian plant used traditionally for
the treatment of breast cancer. Phytother Res 2004;18(7):507-510.
174. Hamid SS, Cheah SH. Generation and characterization of a high-affinity
monoclonal antibody for MUC1 measurement in breast cancer. Hybridoma (Larchmt)
2011;30(2):137-143.
175. Wong SW, Tiong KH, Kong WY, et al. Rapamycin synergizes cisplatin sensitivity
in basal-like breast cancer cells through up-regulation of p73. Breast Cancer Res
Treat 2011;128(2):301-313.

187. Asmah R, Zetti Nadia MZ, Abdah
Kalanchoe laciniata and Piper longum
dependent breast cancer (MCF-7) and
Journal of Medicine and Health Sciences

MA, et al. Effects of Catharanthus roseus,
extracts on the proliferation of hormonecolon cancer (Caco2) cell lines. Malaysian
2005;1(2):105-110

http://apps.medic.upm.edu.my/Ilmiah/mjmhs/VOL1NO2_JUNE2005.pdf
189. Nor Azian AM, Zuraini AR, Rosniza MH, et al. Quantification of Her-2/Neu gene
in breast cancer patients using real time-polymerase chain reaction (Q-PCR) and
correlation with immunohistochemistry findings. Asian Pac J Cancer Prev
2013;14(3):1655-1659

4

http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/%20165559%201.17%20Nor%20Azian%20Abdul%20Murad.pdf
193. Al-Joudi FS, Iskandar Zulkarnain A. Bcl-2 expression and clinico-pathological
correlations in invasive ductal carcinoma of the breast. Jurnal Sains Kesihatan

Malaysia 2010;8(2):59-64
http://journalarticle.ukm.my/3674/1/Bcl-2_Expression_and_Clinico-Pathological.pdf
200. Alabsi AM, Rola A, Abdul Manaf A, et al. Apoptosis induction, cell cycle arrest
and in vitro anticancer activity of gonothalamin in a cancer cell lines. Asian Pac J
Cancer Prev 2012;13(10):5131-5136
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No10/513136%207.22%20Aied%20M%20Alabsi.pdf
205. Hasnan J, Suhaila A, Das Murtey M, et al. Expression of Bax and Bcl-2 in tumour
cells and blood vessels of breast cancer and their association with angiogenesis and
hormonal receptors. Asian Pac J Cancer Prev 2012;13(8):3857-3862
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/385762%207.8%20Hasnan%20Jaafar.pdf
211. Hasnan J, Sharifah Emilia TS, Das Murtey M. Distinctive features of advancing
breast cancer cells and interactions with surrounding stroma observed under the
scanning electron microscope. Asian Pac J Cancer Prev 2012;13(4):1305-1310
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No4/130510%2012.7%20Hasnan%20Jaafa.pdf
230. Mohamed E, Abdul-Rahman PS, Doustjalali SR, et al. Lectin-based
electrophoretic analysis of the expression of the 35 kDa inter-alpha-trypsin inhibitor
heavy chain H4 fragment in sera of patients with five different malignancies.
Electrophoresis 2008;29(12):2645-2650.
238. Munirah MA, Siti-Aishah MA, Reena MZ, et al. Identification of different
subtypes of breast cancer using tissue microarray. Rom J Morphol Embryol

2011;52(2):669-677.
239. Nurismah MI, Noriah O, Suryati MY, et al. E-cadherin expression correlates with
histologic type but not tumour grade in invasive breast cancer. Asian Pac J Cancer
Prev 2008;9(4):699-702.
240. Reena RM, Mastura M, Siti-Aishah MA, et al. Minichromosome maintenance
protein 2 is a reliable proliferative marker in breast carcinoma. Ann Diagn Pathol
2008;12(5):340-343.
241. Sharifah NA, Lee BR, Clarence-Ko CH, et al. C-erbB-2 onco-protein expression in
breast cancer: relationship to tumour characteristics and
5

261. Azura A, Wan Dalila WC, Parveen J, et al. Microarray and quantitative PCR
analysis of gene expression profiles in response to treatment with tomato leaf
extract in mcf-7 breast cancer cells. Asian Pac J Cancer Prev 2012;13(12):6319-6325
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No12/631925%2011.14%20Azura%20Amid.pdf
262. Cheah YH, Azimahtol Hawariah LP, Noor Rain A. Xanthorrhizol exhibits
antiproliferative activity on MCF-7 breast cancer cells via apoptosis induction.
Anticancer Res 2006;26(6B):4527-4534
http://ar.iiarjournals.org/content/26/6B/4527.long
263. Cheah YH, Fariza Juliana N, Rozie S, et al. Combined xanthorrhizol-curcumin

exhibits synergistic growth inhibitory activity via apoptosis induction in human
breast cancer cells MDA-MB-231. Cancer Cell Int 2009;9:1-2867-9-1
http://www.cancerci.com/content/pdf/1475-2867-9-1.pdf
264. Cheah YH, Fariza Juliana N, Tee TT, et al. Antiproliferative property and
apoptotic effect of xanthorrhizol on MDA-MB-231 breast cancer cells. Anticancer Res
2008;28(6A):3677-3689
http://ar.iiarjournals.org/content/28/6A/3677.long
272. Tengku Baharudin N, Jaafar H, Zainuddin Z. Association of mitochondrial DNA
10398 polymorphism in invasive breast cancer in malay population of peninsular
malaysia. Malays J Med Sci 2012;19(1):36-42
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436496/pdf/mjms-19-1-036.pdf
274. Subramani T, Yeap SK, Ho WY, et al. Vitamin C suppresses cell death in MCF-7
human breast cancer cells induced by tamoxifen. J Cell Mol Med 2013;.
275. Hazalin NA, Lim SM, Cole AL, et al. Apoptosis induced by desmethyllasiodiplodin is associated with upregulation of apoptotic genes and downregulation
of monocyte chemotactic protein-3. Anticancer Drugs 2013;24(8):852-861.
277. Salim MI, Supriyanto E, Haueisen J, et al. Measurement of bioelectric and
acoustic profile of breast tissue using hybrid magnetoacoustic method for cancer
detection. Med Biol Eng Comput 2013;51(4):459-466.
281. Abdul Wahab K, Fasihuddin A, Laily D, et al. A study of the in vitro cytotoxic
activity of Gelsemium elegans using human ovarian and breast cancer cell lines.

Trop Biomed 2004;21(2):139-144
http://www.msptm.org/files/C.pdf

6

283. Amran AR, Fatimah M. A new diagnostic approach in the detection of breast
carcinoma: electrical impedance measurement with TransScan TS 2000.
International Medical Journal (IIUM) 2007;6(2)
http://www.e-imj.com/Vol6-No2/Vol6-No2-B8.htm
284. Bong IPN, Zakaria Z, Muhammad R, et al. Expression and mutational analysis
of GATA3 in Malaysian breast carcinomas. Malays J Pathol 2010;32(2):117-122
http://www.mjpath.org.my/2010.2/breast_cancer.pdf
286. Ee GC, Lim CK, Rahmat A, et al. Cytotoxic activities of chemical constituents
from Mesua daphnifolia. Trop Biomed 2005;22(2):99-102
http://www.msptm.org/files/99_-_102_Cytotoxic_activities.pdf
288. Erbas H, Erten O, Irfanoglu ME. Prostatic acid phosphatase in breast cyst fluid.
Malays J Pathol 2007;29(2):95-99.
292. Haryati Shila MW. The Effects Of Newcastle Disease Virus (ndv) On Breast
Cancer Cell Lines. 2003;.
293. Gurjeet K, Rosli I, Lee SK, et al. Assessment of correlation between
clinicopathological features and lymph node metastases in breast cancer. Internet
Journal of Pathology 2007;5(2)
http://www.ispub.com/ostia/index.php?
xmlPrinter=true&xmlFilePath=journals/ijpa/vol5n2/lymph.xml
301. Latifah SY, Faujan A, Ooi CL, et al. Betulinic acid was more cytotoxic towards
the human breast cancer cell line mda-mb-231 than the human promyelocytic
leukimia cell line h1-60. Malaysian Journal of Pharmaceutical Sciences 2009;7(1):2337
http://www.usm.my/mjps/MJPS%207%281%29%202009/MJPS%207.1.3.pdf
308. Looi LM, Cheah PL, Zhao W, et al. CD44 expression and axillary lymph node
metastasis in infiltrating ductal carcinoma of the breast. Malays J Pathol
2006;28(2):83-86
http://www.mjpath.org.my/2006.2/03-CD44.pdf
309. Looi LM, Ng MH, Cheah PL. Telomerase activation in neoplastic cell
immortalization and tumour progression. Malays J Pathol 2007;29(1):33-35
http://www.mjpath.org.my/2007.1/04Telemerase.pdf
310. Naidu R, Yip CH, Taib NA. Genetic variations in transcription factor 7-like 2
(TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with
breast cancer risk and clinico-pathological parameters. Med Oncol 2012;29(2):411417.
7

316. Nesaretnam K, Gomez PA, Selvaduray KR, et al. Tocotrienol levels in adipose
tissue of benign and malignant breast lumps in patients in Malaysia. Asia Pac J Clin
Nutr 2007;16(3):498-504
http://apjcn.nhri.org.tw/server/APJCN/16/3/498.pdf
323. Pau Ni IB, Zakaria Z, Muhammad R, et al. Gene expression patterns distinguish
breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res
Pract 2010;206(4):223-228.
325. Othman MI, Majid MI, Singh M, et al. Isolation, identification and quantification
of differentially expressed proteins from cancerous and normal breast tissues. Ann
Clin Biochem 2008;45(Pt 3):299-306.
328. Sharifah Sakinah SA, Nallappan M, Azimahtol Hawariah LP. Zerumbone exerts
antiproliferative activity via apoptosis on HepG2 cells. Malaysian Journal of
Biochemistry and Molecular Biology 2007;15(1):19-23
http://ejum.fsktm.um.edu.my/ArticleInformation.aspx?ArticleID=577
329. Rumiza AR, Azimahtol Hawariah LP. The antiproliferative effects of Zingiber
zerumbet extracts and fractions on the growth of human breast carcinoma cell lines.
Malaysian Journal of Pharmaceutical Sciences 2005;3(1):45-52
http://myais.fsktm.um.edu.my/6831/1/the_antiprolife_vol3_no1_(45-52)2005.PDF
http://www.pha.usm.my/pharmacy/Webpage%20journal/abstract/3.1-5.pdf
333. Suppiah S, Rahmat K, Mohd-Shah MN, et al. Improved diagnostic accuracy in
differentiating malignant and benign lesions using single-voxel proton MRS of the
breast at 3 T MRI. Clin Radiol 2013;68(9):e502-10.
335. Tan CM. A Development of a Cancer Information System by Using Information
Retrieval Techniques. 2006;.
339. Wong SF, Seow HF, Lai LC. Effect of cathepsin D and prostate specific antigen
on latent transforming growth factor-beta in breast cancer cell lines. Malays J Pathol
2003;25(2):129-134
http://www.mjpath.org.my/past_issue/MJP2003.2/05%20Breast%20Cancer.pdf
342. Nesaretnam K, Radhakrishnan A, Selvaduray KR, et al. Effect of palm oil
carotene on breast cancer tumorigenicity in nude mice. Lipids 2002;37(6):557-560.
345. Tan BS, Tiong KH, Muruhadas A, et al. CYP2S1 and CYP2W1 mediate 2-(3,4dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast
and colorectal cancer cells. Mol Cancer Ther 2011;10(10):1982-1992.

8

359. Khaledi H, Alhadi AA, Yehye WA, et al. Antioxidant, cytotoxic activities, and
structure-activity relationship of gallic acid-based indole derivatives. Arch Pharm
(Weinheim) 2011;344(11):703-709.
360. Tan BS, Kang O, Mai CW, et al. 6-Shogaol inhibits breast and colon cancer cell
proliferation through activation of peroxisomal proliferator activated receptor
gamma (PPARgamma). Cancer Lett 2013;336(1):127-139.
361. Sani HA, Rahmat A, Ismail M, et al. Potential anticancer effect of red spinach
(Amaranthus gangeticus) extract. Asia Pac J Clin Nutr 2004;13(4):396-400
http://apjcn.nhri.org.tw/server/APJCN/13/4/396.pdf
364. In LL, Azmi MN, Ibrahim H, et al. 1'S-1'-acetoxyeugenol acetate: a novel
phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of
paclitaxel in MCF-7 cells through NF-kappaB inactivation. Anticancer Drugs
2011;22(5):424-434.
367. Ooi KL, Tengku Muhammad TS, Lim CH, et al. Apoptotic effects of Physalis
minima L. chloroform extract in human breast carcinoma T-47D cells mediated by cmyc-, p53-, and caspase-3-dependent pathways. Integr Cancer Ther 2010;9(1):7383.
370. Al-Joudi FS, Iskandar ZA, Rusli J. The expression of p53 in invasive ductal
carcinoma of the breast: a study in the North-East States of Malaysia. Med J
Malaysia 2008;63(2):96-99
http://www.e-mjm.org/2008/v63n2/Invasive_Ductal_Carcinoma.pdf
371. Al-Joudi FS, Iskandar ZA, Imran AK. Correlations in survivin expression with the
expression of p53 and bcl-2 in invasive ductal carcinoma of the breast. Southeast
Asian J Trop Med Public Health 2007;38(5):904-910.
372. Al-Joudi FS, Iskandar ZA, Imran AK. Survivin expression correlates with
unfavourable prognoses in invasive ductal carcinoma of the breast. Med J Malaysia
2007;62(1):6-8
http://www.e-mjm.org/2007/v62n1/invasive_Ductal_Carcinoma.pdf
373. Al-Joudi FS, Iskandar ZA, Hasnan J, et al. Expression of survivin and its
clinicopathological correlations in invasive ductal carcinoma of the breast.
Singapore Med J 2007;48(7):607-614
http://smj.sma.org.sg/4807/4807a1.pdf
374. Al-Joudi FS, Iskandar ZA. Autoantibodies to survivin in the sera of patients with
infiltrating ductal carcinoma of the breast. Med J Malaysia 2006;61(3):302-306
http://www.e-mjm.org/2006/v61n3/Ductal_Carcinoma.pdf

9

375. Al-Joudi FS. Prognostic value of an index for serum globulin compensation in
colon and breast cancers. Singapore Med J 2005;46(12):710-713
http://www.sma.org.sg/smj/4612/4612a5.pdf
376. Al-Joudi FS, Fahme AKK, Ismarulyusda I, et al. Expression of human
mammaglobin and clinicopathologic correlations in breast cancer: the findings in
Malaysia. Indian J Pathol Microbiol 2011;54(2):284-289
http://ijpmonline.org/article.asp?issn=03774929;year=2011;volume=54;issue=2;spage=284;epage=289;aulast=Al-Joudi
377. Abrahim NN, Kanthimathi MS, Abdul-Aziz A. Piper betle shows antioxidant
activities, inhibits MCF-7 cell proliferation and increases activities of catalase and
superoxide dismutase. BMC Complement Altern Med 2012;12:220-6882-12-220
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533855/
378. Ahmad ZA, Yeap SK, Ali AM, et al. scFv antibody: principles and clinical
application. Clin Dev Immunol 2012;2012:980250
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312285/
381. Chong HZ, Rahmat A, Yeap SK, et al. In vitro cytotoxicity of Strobilanthes
crispus ethanol extract on hormone dependent human breast adenocarcinoma MCF7 cell. BMC Complement Altern Med 2012;12:35-6882-12-35
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377542/
382. Ebrahimi Nigjeh S, Yusoff FM, Mohamed Alitheen NB, et al. Cytotoxic effect of
ethanol extract of microalga, Chaetoceros calcitrans, and its mechanisms in
inducing apoptosis in human breast cancer cell line. Biomed Res Int
2013;2013:783690
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591159/
383. Golbabapour S, Pang WW, George J, et al. Chemically induced breast tumors in
rats are detectable in early stages by contrast enhanced magnetic resonance
imaging but not by changes in the acute-phase reactants in serum. Int J Mol Sci
2011;12(2):1030-1040
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083687/
384. Guure CB, Ibrahim NA, Adam MB. Bayesian inference of the Weibull model
based on interval-censored survival data. Comput Math Methods Med
2013;2013:849520
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556417/

10

386. Ho WY, Yeap SK, Ho CL, et al. Development of multicellular tumor spheroid
(MCTS) culture from breast cancer cell and a high throughput screening method
using the MTT assay. PLoS One 2012;7(9):e44640
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435305/
387. Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, et al. Hippuric acid nanocomposite
enhances doxorubicin and oxaliplatin-induced cytotoxicity in MDA-MB231, MCF-7
and Caco2 cell lines. Drug Des Devel Ther 2013;7:25-31
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549678/
388. Ismail NI, Kaur G, Hashim H, et al. S100A4 overexpression proves to be
independent marker for breast cancer progression. Cancer Cell Int 2008;8:12-28678-12
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542991/
389. Ismail NI, Kaur G, Hashim H, et al. Nuclear localization and intensity of staining
of nm23 protein is useful marker for breast cancer progression. Cancer Cell Int
2008;8:6-2867-8-6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2396598/
390. Jada SR, Matthews C, Saad MS, et al. Benzylidene derivatives of
andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing
G(1) arrest and apoptosis. Br J Pharmacol 2008;155(5):641-654
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584933/
395. Lee HH, Lim CA, Cheong YT, et al. Comparison of protein expression profiles of
different stages of lymph nodes metastasis in breast cancer. Int J Biol Sci
2012;8(3):353-362
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291852/
396. Lee SH, Jaganath IB, Wang SM, et al. Antimetastatic effects of Phyllanthus on
human lung (A549) and breast (MCF-7) cancer cell lines. PLoS One
2011;6(6):e20994
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116853/
397. Li YT, Chua MJ, Kunnath AP, et al. Reversing multidrug resistance in breast
cancer cells by silencing ABC transporter genes with nanoparticle-facilitated
delivery of target siRNAs. Int J Nanomedicine 2012;7:2473-2481
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373294/

11

398. Liang S, Singh M, Gam LH. The differential expression of aqueous soluble
proteins in breast normal and cancerous tissues in relation to stage and grade of
patients. J Biomed Biotechnol 2010;2010:516469
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004415/
399. Lim LY, Vidnovic N, Ellisen LW, et al. Mutant p53 mediates survival of breast
cancer cells. Br J Cancer 2009;101(9):1606-1612
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778523/
401. Looi CY, Arya A, Cheah FK, et al. Induction of apoptosis in human breast cancer
cells via caspase pathway by vernodalin isolated from Centratherum
anthelminticum (L.) seeds. PLoS One 2013;8(2):e56643
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577860/
403. Nazri A, Lio P. Investigating meta-approaches for reconstructing gene networks
in a mammalian cellular context. PLoS One 2012;7(1):e28713
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253778/
404. Nesaretnam K, Meganathan P, Veerasenan SD, et al. Tocotrienols and breast
cancer: the evidence to date. Genes Nutr 2012;7(1):3-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250526/
406. Othman F, Motalleb G, Lam Tsuey Peng S, et al. Effect of Neem Leaf Extract
(Azadirachta indica) on c-Myc Oncogene Expression in 4T1 Breast Cancer Cells of
BALB/c Mice. Cell J 2012;14(1):53-60
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635821/
407. Othman F, Motalleb G, Lam Tsuey Peng S, et al. Extract of Azadirachta indica
(Neem) Leaf Induces Apoptosis in 4T1 Breast Cancer BALB/c Mice. Cell J
2011;13(2):107-116
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584456/
415. Thirthagiri E, Lee SY, Kang P, et al. Evaluation of BRCA1 and BRCA2 mutations
and risk-prediction models in a typical Asian country (Malaysia) with a relatively low
incidence of breast cancer. Breast Cancer Res 2008;10(4):R59
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575532/
416. Toh GT, Kang P, Lee SS, et al. BRCA1 and BRCA2 germline mutations in
Malaysian women with early-onset breast cancer without a family history. PLoS One
2008;3(4):e2024
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2295262/
12

417. Wong RS, Mohamed SM, Nadarajah VD, et al. Characterisation of the binding
properties of Bacillus thuringiensis 18 toxin on leukaemic cells. J Exp Clin Cancer Res
2010;29:86-9966-29-86
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909967/
418. Yaacob NS, Hamzah N, Nik Mohamed Kamal NN, et al. Anticancer activity of a
sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast
and prostate cancer cells in vitro. BMC Complement Altern Med 2010;10:42-688210-42
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924269/

13